Compounds > technetium tc 99m pentetate
Page last updated: 2024-09-05

technetium tc 99m pentetate and Cerebrovascular Moyamoya Disease

technetium tc 99m pentetate has been researched along with Cerebrovascular Moyamoya Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Honda, N; Inoue, Y; Machida, K; Mamiya, T; Momose, T; Takahashi, T; Tsutsumi, K1
Honda, N; Inoue, Y; Machida, K; Momose, T; Tsutsumi, K1

Other Studies

2 other study(ies) available for technetium tc 99m pentetate and Cerebrovascular Moyamoya Disease

ArticleYear
An approach to cerebral vasodilatory capacity in unilateral and bilateral cerebrovascular diseases using radiolabeled human serum albumin.
    Clinical nuclear medicine, 1995, Volume: 20, Issue:4

    Topics: Acetazolamide; Adolescent; Adult; Aged; Carotid Stenosis; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Child; Female; Humans; Male; Middle Aged; Moyamoya Disease; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Tomography, Emission-Computed, Single-Photon; Vasodilation

1995
Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:11

    Topics: Acetazolamide; Cerebral Infarction; Cerebrovascular Circulation; Humans; Male; Middle Aged; Moyamoya Disease; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Tomography, Emission-Computed, Single-Photon; Vasodilation

1993